We used FSHD-like mouse models as a primary discovery tool to identify miRNAs altered by variable DUX4 expression in skeletal muscles for evaluation as FSHD biomarkers in serum analysis. Here, DUX4 is linked to facioscapulohumeral muscular dystrophy.